Screener
Harvard Bioscience HBIO Q2 2025 earnings
Reported August 11, 2025 · Before market open
Revenue$20.5MBeat by $1.5M
EPS-$0.01Beat by $0.02
Revenue estimate$19.0M
EPS estimate-$0.03
Next report
Nov 5, 2026 (in 2 months)Revenue estimate$21.8M
EPS estimate-$0.17
Versus estimates
Revenue
Diluted EPS
FAQ
- When did Harvard Bioscience report Q2 2025 earnings?
- Harvard Bioscience (HBIO) reported Q2 2025 earnings on August 11, 2025 before market open.
- What were Harvard Bioscience's Q2 2025 revenue and EPS?
- Harvard Bioscience reported revenue of $20.5M and eps of $-0.01 for Q2 2025.
- Did Harvard Bioscience beat estimates in Q2 2025?
- Revenue beat the consensus estimate of $19.0M by $1.5M. EPS beat the consensus estimate of $-0.03 by $0.02.
- How did Harvard Bioscience's Q2 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 11.5% from $23.1M a year earlier and eps grew 66.7% from $-0.03.
- Where can I find Harvard Bioscience's Q2 2025 SEC filings?
- You can read the 8-K earnings release (0001171843-25-005288) and the 10-Q periodic report (0001171843-25-005287) directly on SEC EDGAR. The filing index links above go to sec.gov.
